4-(三氟甲基)烟酸甲酯 | 175204-82-7

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-(三氟甲基)烟酸甲酯
• 中文别名: 甲基4-(三氟甲基)烟酸；4-三氟甲基烟酸甲酯
• 英文名称: methyl 4-trifluoromethylpyridine-3-carboxylate
• 英文别名: methyl 4-trifluoromethylnicotinate；Methyl 4-trifluormethylpyridine-3-carboxylate；Methyl 4-(trifluoromethyl)nicotinate；methyl 4-(trifluoromethyl)pyridine-3-carboxylate
• CAS: 175204-82-7
• 化学式: C₈H₆F₃NO₂
• 分子量: 205.136
• InChiKey: RFUABQNZKSSKRX-UHFFFAOYSA-N

物化性质

• 沸点：
  100°C 15mm
• 密度：
  1.331±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  39.2
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

SDS

Name:	Methyl 4-(trifluoromethyl)nicotinate 97% Material Safety Data Sheet
Synonym:	Methyl 4-(trifluoromethyl)pyridine-3-carboxylat
CAS:	175204-82-7

Section 1 - Chemical Product MSDS Name:Methyl 4-(trifluoromethyl)nicotinate 97% Material Safety Data Sheet
Synonym:Methyl 4-(trifluoromethyl)pyridine-3-carboxylat

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
175204-82-7	Methyl 4-(trifluoromethyl)nicotinate	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 175204-82-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 100 deg C @15mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6F3NO2
Molecular Weight: 205

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 175204-82-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Methyl 4-(trifluoromethyl)nicotinate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 175204-82-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 175204-82-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 175204-82-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(三氟甲基)烟酸甲酯 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 生成 (4-三氟甲基-3-吡啶)-甲醇
  参考文献：
  名称：

  Tocolytic oxytocin receptor antagonists

  摘要：

  这项发明涉及某些新型苯并噁唑酮化合物及其衍生物，它们的合成以及它们作为催产素受体拮抗剂的用途。这些化合物的一个应用是用于治疗哺乳动物，尤其是人类的早产。这些化合物使哺乳动物子宫收缩放松的能力也使它们在治疗痛经和在剖宫产前停止分娩方面非常有用。

  公开号：

  US05756497A1
• 作为产物：
  描述：

  methyl 3-(4,4,4-trifluoro-3-oxo-1-butenylamino)acrylate 在 盐酸 作用下， 以 甲醇 、 Li₂CO₃ 为溶剂， 生成 4-(三氟甲基)烟酸甲酯
  参考文献：
  名称：

  Preparation of 4-haloalkylnicotinic esters

  摘要：

  一种制备式(I)的4-卤代烷基烟酸酯的方法，其中RF为(C1-C4)卤代烷基，R为(C1-C6)烷基，包括以下步骤： a)在减压下用式(II)的氨基酮与式(III)至(V)的化合物进行缩合反应，其中 (R1Z)CH═CH—COOR   (III), (R1Z)2CH—CH2—COOR   (IV), HC≡C—COOR   (V), R1为(C1-C6)烷基，Z为O、S、NR1或C(O)O，得到式(VI)和/或(VII)的化合物： RF—C(O)—CH═CH—NH—CH═CH—COOR   (VI) RF—C(O)—CH═CH—NH—CH(ZR1)—CH2—COOR   (VII) b)将反应产物进行环合反应。

  公开号：

  US20030083502A1

文献信息

• [EN] BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE BENZOFURANE UTILISES POUR TRAITER DES TROUBLES HYPERPROLIFERANTS
  申请人：BAYER PHARMACEUTICALS CORP

  公开号：WO2005014566A1

  公开（公告）日：2005-02-17

  The invention relates to novel heterocycles of formula (I), processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.

  这项发明涉及到式(I)的新异环化合物，以及用于制备这些化合物的方法，以及它们用于制备治疗或预防疾病的药物，特别是治疗过度增殖性疾病的药物。
• [EN] BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE BENZOFURANE ET DE BENZOTHIOPHENE UTILISES DANS LE TRAITEMENT DE TROUBLES HYPERPROLIFERATIFS
  申请人：BAYER PHARMACEUTICALS CORP

  公开号：WO2003072561A1

  公开（公告）日：2003-09-04

  This invention relates to novel benzofuran and benzothiophene derivatives of the general formula and their use for the treatment of hyper-proliferative disorders.

  这项发明涉及一般式的新型苯并呋喃和苯并噻吩衍生物及其用于治疗高增殖性疾病的用途。
• Tocolytic oxytocin receptor antagonists
  申请人：Merck & Co., Inc.

  公开号：US05756497A1

  公开（公告）日：1998-05-26

  This invention relates to certain novel benzoxazinone compounds and derivatives thereof, their synthesis, and their use as oxytocin receptor antagonists. One application of these compounds is in the treatment of preterm labor in mammals, especially humans. The ability of the compounds to relax uterine contractions in mammals also makes them useful for treating dysmenorrhea and stopping labor prior to cesarean delivery.

  这项发明涉及某些新型苯并噁唑酮化合物及其衍生物，它们的合成以及它们作为催产素受体拮抗剂的用途。这些化合物的一个应用是用于治疗哺乳动物，尤其是人类的早产。这些化合物使哺乳动物子宫收缩放松的能力也使它们在治疗痛经和在剖宫产前停止分娩方面非常有用。
• Dearomatization of electron poor six-membered N-heterocycles through [3 + 2] annulation with aminocyclopropanes
  作者：Johannes Preindl、Shyamal Chakrabarty、Jérôme Waser

  DOI：10.1039/c7sc03197a

  日期：——

  Many abundant and highly bioactive natural alkaloids contain an indolizidine skeleton. A simple, high yielding method to synthesize this scaffold from N-heterocycles was developed. A wide range of pyridines, quinolines and isoquinolines reacted with Donor-Acceptor (DA)-aminocyclopropanes via an ytterbium(III) catalyzed [3+2] annulation reaction to give tetrahydroindolizine derivatives. The products

  许多丰富且具有高生物活性的天然生物碱都含有吲哚并立啶骨架。开发了一种简单，高产的方法，可从N-杂环合成该支架。各种吡啶，喹啉和异喹啉通过Don（III）催化的[3 + 2]环化反应与施主-受体（DA）-氨基环丙烷反应，得到四氢吲哚嗪衍生物。获得具有高非对映选择性（dr> 20：1）的产物作为抗异构体。另外，形成的缩醛可以通过形成亚胺，然后还原或添加亲核试剂而容易地转化为仲胺和叔胺。这种转化构成了贫电子的六元杂环通过DA环丙烷的[3 + 2]环芳烃脱芳香化作用的第一个例子。
• [EN] PYRROLONE DERIVATIVES AS HERBICIDES<br/>[FR] DÉRIVÉS DE PYRROLONE UTILISÉS EN TANT QU'HERBICIDES
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：WO2015018432A1

  公开（公告）日：2015-02-12

  The invention relates to pyrrolone compounds of the formula (I) wherein X, R1, R2, R3 and A are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.

  该发明涉及公式(I)的吡咯酮化合物，其中X、R1、R2、R3和A如规范中所定义。此外，本发明涉及用于制备公式(I)化合物的过程和中间体，包括这些化合物的除草剂组合物，以及使用这些化合物控制植物生长的方法。